得意牛
发表于 2025-3-23 12:30:13
A. A. Longens, a number of issues are still open for investigation in front-line therapy of this disease. These include, among others, improvements in early death rate, the role of arsenic trioxide (ATO) and maintenance treatment, and, finally, optimization of molecular monitoring to better identify patients
spondylosis
发表于 2025-3-23 15:13:33
http://reply.papertrans.cn/43/4228/422792/422792_12.png
disparage
发表于 2025-3-23 21:30:07
http://reply.papertrans.cn/43/4228/422792/422792_13.png
placebo
发表于 2025-3-24 00:17:35
http://reply.papertrans.cn/43/4228/422792/422792_14.png
sultry
发表于 2025-3-24 06:02:43
http://reply.papertrans.cn/43/4228/422792/422792_15.png
令人悲伤
发表于 2025-3-24 10:15:31
David Sedleyens, a number of issues are still open for investigation in front-line therapy of this disease. These include, among others, improvements in early death rate, the role of arsenic trioxide (ATO) and maintenance treatment, and, finally, optimization of molecular monitoring to better identify patients
得意牛
发表于 2025-3-24 12:29:01
http://reply.papertrans.cn/43/4228/422792/422792_17.png
MAG
发表于 2025-3-24 18:45:29
Daniel W. Grahamved antileukemic treatment, ED rates still remain high. Clinical trials usually report ED rates between 3 and 10%, while early mortality in population-based studies ranges between 10 and 30%. Thus, clinical trials normally underestimate the ED risk due to exclusion of patients with the highest risk
STENT
发表于 2025-3-24 22:19:15
C. C. W. Taylorembolism with regard to mortality, the occurrence of cardiovascular complications and the extent of arterial hypoxemia..In 85 patients and in a second study in 139 patients with acute massive pulmonary embolism a right-to-left shunt was diagnosed by contrast echocardiography. A patent foramen ovale
Pert敏捷
发表于 2025-3-25 00:18:55
http://reply.papertrans.cn/43/4228/422792/422792_20.png